Table 1.
Intravitreal Radioactivity Levels (Bq/mL)
| Day | Bev. 1 | Bev. 2 | Bev. 3 | Ran. 1 | Ran. 2 | Ran. 3 |
|---|---|---|---|---|---|---|
| 0 | 175,370.0 | 205,250.0 | 178,970.0 | 167,730.0 | 116,000.0 | 164,540.0 |
| 2 | 848,61.5 | 106,740.0 | 89,862.3 | 89,780.3 | 50,111.7 | 69,510.8 |
| 5 | 312,47.2 | 383,12.8 | 337,22.5 | 210,29.2 | 140,30.5 | 196,04.7 |
| 7 | 155,23.8 | 198,24.4 | 170,06.6 | 5,933.5 | 5,946.1 | 8,350.8 |
| 14 | 1,549.1 | 1,929.9 | 1,695.3 | 470.6 | 275.7 | 454.5 |
| 21 | 174.5 | 44.3 | 161.4 | 31.6 | 16.7 | 31.1 |
| 28 | 17.2 | 23.8 | 15.9 | 4.9 | 8.2 | 9.1 |
| 35 | 7.6 | 5.1 | 9.1 | |||
| Day | Bev. 1-PPV | Bev. 2-PPV | Bev. 3-PPV | Ran. 1-PPV | Ran. 2-PPV | Ran. 3-PPV |
| 0 | 327,500.0 | 318,600.0 | 360,480.0 | 278,150.0 | 234,510.0 | 225,600 |
| 2 | 22,463.8 | 107,000.0 | 16,220.1 | 4,972.4 | 2,186.5 | 663.4 |
| 5 | 2,186.6 | 27,782.9 | 1,663.8 | 1,322.1 | 281.0 | 143.8 |
| 7 | 1,043.9 | 164,15.4 | 707.2 | 650.9 | 169.7 | 67.0 |
| 14 | 108.0 | 3,342.2 | 69.8 | 60.1 | 35.8 | 16.9 |
| 21 | 21.8 | 630.4 | 16.2 | 9.6 | 15.7 | 7.1 |
| 28 | 8.6 | 110.2 | 5.9 | |||
| 35 | 33.3 | |||||
| Day | Bev. 1-PPL | Bev. 2-PPL | Bev. 3-PPL | Ran. 1-PPL | Ran. 2-PPL | Ran. 3-PPL |
| 0 | 332,020.0 | 365,280.0 | 346,410.0 | 309,570.0 | 245,630.0 | 272,970.0 |
| 2 | 308,57.3 | 9,899.4 | 421,50.5 | 48,136.8 | 32,017.1 | 14,947.9 |
| 5 | 1,760.8 | 698.1 | 2,357.7 | 2,456.4 | 1,835.3 | 168.7 |
| 7 | 477.9 | 321.7 | 596.8 | 169.0 | 286.8 | 38.8 |
| 14 | 31.5 | 39.9 | 71.0 | 11.4 | 10.0 | 9.3 |
| 21 | 6.0 | 10.0 | 15.3 | 4.6 | 5.1 | 7.1 |
Bev., bevacizumab; PPL, pars plana lensectomy; PPV, pars plana vitrectomy; Ran., ranibizumab.